References
- Cruickshank JC. 1988. Leiomyosarcoma metastatic to the thyroid gland. Ear, Nose, and Throat Journal 67:899–910.
- Echt G, Jepson J, Steel J et al. 1990. Treatment of uterine sarcomas. Cancer 66: 35–39.
- Gadducci A, Landoni F, Sartori E et al. 1996. Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecologic Oncology 62:25–32.
- Giuntoli RL, Bristow RE. 2004. Uterine leiomyosarcoma: present management. Current Opinion in Oncology 96:524–527.
- Gohji K, Kizaki T, Fujii A. 1997. Bilateral adrenal tumours: a case report of an unusual manifestation of mesenteric leiomyosarcoma. British Journal of Urology 79:479–480.
- Kapp DS, Shin JY, Chan JK. 2008. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 112:820–830.
- Lin CH, Yeh CN, Chen MF. 2003. Breast metastasis from uterine leiomyosarcoma: a case report. Archives of Gynecology and Obstetrics 267:233–235.
- Ren W, Korchin B, Lahat G et al. 2008. Combined vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft tissue sarcoma. Clinical Cancer Research 14:5466–5475.
- Rose PG, Piver MS, Tsukada Y et al. 1989. Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer 63:935–938.
- Sahin D, Cetiner H, Mirapoglu S et al. 2010. An infantile leiomyosarcoma that metastasized from the small intestine to the adrenal gland. Fetal and Pediatric Pathology 29:299–304.
- Saiz AD, Sachdev U, Brodman ML et al. 1998. Metastatic uterine leiomyosarcoma presenting as a primary sarcoma of the parotid gland. Obstetrics and Gynecology 92:667–668.
- Wronski M, de Palma P, Arbit E. 1994. Leiomyosarcoma of the uterus metastatic to brain: a case report and a review of the literature. Gynecologic Oncology 54:237–241.
- Zafrakas M, Theodoridis TD, Zepiridis L et al. 2008. KIT protein expression in uterine sarcomas: an immunohistochemical study and review of the literature. European Journal of Gynaecological Oncology 29:264–266.